<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Assessment and management of low blood pressure in extremely preterm infants
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Assessment and management of low blood pressure in extremely preterm infants
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Assessment and management of low blood pressure in extremely preterm infants
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Beau Batton, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard Martin, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 22, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1462691202">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cardiovascular assessment and management of blood pressure (BP) in extremely preterm (EPT) infants (gestational age [GA] &lt;28
         <sup>
         </sup>
         weeks) is challenging due to the presence of multiple disease processes, unpredictable adaptation to extrauterine life, and difficulty assessing organ perfusion. Although there are data that suggest EPT infants with low BP are at an increased risk for adverse outcomes, low BP in EPT infants with adequate perfusion may not be an independent risk factor for poor outcome. By contrast, a minority (approximately 10 to 15 percent) of EPT infants with low BP have evidence of poor perfusion (shock). These infants require immediate attention to restore adequate perfusion.
        </p>
        <p>
         This topic will discuss the challenges of cardiovascular assessment in EPT infants and will review the approach to the evaluation and management of low BP in EPT infants with adequate perfusion. Evaluation and management of neonatal shock is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126605.html" rel="external">
          "Neonatal shock: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H875812233">
         <span class="h1">
          DEFINITIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Extremely preterm (EPT) infant – Infants born &lt;28
         <sup>
         </sup>
         weeks gestational age (GA).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Extremely low birth weight (ELBW) infant – Infants born with birth weight (BW) &lt;1000 g.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adequate peripheral perfusion – Warm, pink skin with capillary refill &lt;4 seconds and strong pulses to all extremities; good urine output; no laboratory evidence of end-organ dysfunction (eg, lactic acidosis).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poor peripheral perfusion – Signs of poor peripheral perfusion may include delayed capillary refill, mottling of the skin, cool extremities, weak pulses, oliguria, metabolic acidosis, and elevated serum lactate level. (See
         <a class="local">
          'Assessment of perfusion'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low BP – Unlike older patients, in whom low BP is typically defined as &lt;5
         <sup>
          th
         </sup>
         percentile for age and for whom interventions are often initiated at this threshold, there is not a clear numeric threshold for low BP in EPT infants at which intervention improves outcome (
         <a class="graphic graphic_figure graphicRef110237" href="/z/d/graphic/110237.html" rel="external">
          figure 1
         </a>
         ). Nevertheless, as BP decreases below the 10
         <sup>
          th
         </sup>
         or 5
         <sup>
          th
         </sup>
         percentile in EPT infants, ongoing frequent assessment of perfusion and BP is required to detect any subsequent signs of impaired perfusion. (See
         <a class="local">
          'BP alone is an insufficient measure of perfusion'
         </a>
         below and
         <a class="local">
          'Assessment of perfusion'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3868542968">
         <span class="h1">
          CHALLENGES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although low blood pressure (BP) values based on published normative data are commonly observed in extremely preterm (EPT) infants with adequate perfusion, numerous factors make it difficult to determine if and when intervention for low BP is warranted. BP management is based on limited observational data, varies amongst clinical centers, and there remain large knowledge gaps [
         <a href="#rid1">
          1-4
         </a>
         ]. This is particularly true for EPT infants with adequate peripheral perfusion. In contrast, a small minority (approximately 10 to 15 percent) of EPT infants with both low BP and poor perfusion are in shock and require immediate attention to restore adequate perfusion. (See
         <a class="medical medical_review" href="/z/d/html/126605.html" rel="external">
          "Neonatal shock: Management"
         </a>
         .)
        </p>
        <p>
         The following sections present the available but limited evidence regarding these issues that make it challenging to determine the best practice for BP management in EPT infants:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physiologic changes to the cardiovascular system in the immediate postnatal period that impact BP. (See
         <a class="medical medical_review" href="/z/d/html/4970.html" rel="external">
          "Physiologic transition from intrauterine to extrauterine life"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Challenge of obtaining reliable and consistent measured BP values.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         BP evaluation and intervention:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inability to define a clinically worrisome BP value (ie, BP target value).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Challenge of determining if there is a relationship between untreated low BP in EPT infants with good perfusion and poor outcomes, and whether there is a likelihood of subsequent development of shock.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Challenge of determining the impact of therapies intended to increase BP on patient outcomes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Difficulty assessing organ perfusion with BP alone.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3206285792">
         <span class="h2">
          Physiological changes in BP
         </span>
         <span class="headingEndMark">
          —
         </span>
         BP values in EPT infants vary considerably depending on the birth weight (BW), gestational age (GA), and postnatal age (
         <a class="graphic graphic_figure graphicRef110236" href="/z/d/graphic/110236.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef110237" href="/z/d/graphic/110237.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid5">
          5-7
         </a>
         ]. Even among infants with the same GA and postnatal age, there is considerable BP variability. Most EPT infants with BP values &lt;10
         <sup>
          th
         </sup>
         percentile for published normative values have adequate perfusion. These "low" BP values are usually transient, reflect expected physiologic changes following delivery, and are not a sign of an underlying disease process. In addition, the difference between the 5
         <sup>
          th
         </sup>
         and 10
         <sup>
          th
         </sup>
         BP percentile for EPT is only 1 to 2 mmHg during the first few postnatal days. BP increases spontaneously with increasing postnatal age at a rate of approximately 4 mmHg per day during the first 72 hours after birth [
         <a href="#rid1">
          1,2,5,6
         </a>
         ]. These factors make it difficult to determine what is a normal BP, when is BP too low, increasing too slowly, or indicative of a pathological process, which cannot otherwise be discerned without other clinical data. The spontaneous rise in BP after birth also makes it difficult to assess the response to therapies administered to increase BP [
         <a href="#rid6">
          6,8
         </a>
         ].
        </p>
        <p>
         By contrast, low BP or BP that fails to rise normally associated with evidence of poor perfusion (ie, shock) is pathologic. In such situations, prompt evaluation and intervention targeted at the most likely cause is indicated. (See
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Etiologic classification'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2574149072">
         <span class="h2">
          Accuracy and reliability of BP measurements
         </span>
         <span class="headingEndMark">
          —
         </span>
         In EPT infants, BP can be measured noninvasively with a cuff or invasively using pressure transducer on an indwelling umbilical arterial catheter (UAC). Radial arterial catheters are rarely used in this population due to the risk of distal ischemia.
        </p>
        <p>
         Regardless of the method used, obtaining a reliable and consistent BP value is challenging in this population [
         <a href="#rid9">
          9-14
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Noninvasive measurement
         </strong>
         – Reliable noninvasive BP measurement requires attention to BP cuff size, location, and method of measurement [
         <a href="#rid14">
          14
         </a>
         ]. Specifically, clinicians should use the appropriate-size cuff (
         <a class="graphic graphic_figure graphicRef103066" href="/z/d/graphic/103066.html" rel="external">
          figure 3
         </a>
         ) for the chosen site for obtaining the BP (upper arm versus thigh) and minimize movement of the extremity during the measurement. Most devices used for noninvasive BP measurements measure mean arterial BP (MAP) and estimate the systolic and diastolic BP based on mathematical algorithms unique to the monitor and device manufacturer. As a result, noninvasive BP values can vary significantly from device to device and when compared with those obtained through a UAC. While numerous studies have suggested MAP values obtained from a BP cuff may be higher than those obtained from a UAC, this is not universally the case and several studies have reported lower MAP values with a BP cuff than an invasive measurement from a UAC.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As a result, if noninvasive BP measurements are used routinely, clinicians need to know the correlation between values obtained from a UAC and noninvasive BP measurements obtained using the devices at their center.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Invasive measurement
         </strong>
         – For invasive BP values obtained through a UAC, the pressure transducer needs to be appropriately leveled, a reasonable waveform needs to be obtained, and the potential impact of infusions through the catheter needs to be considered. (See
         <a class="medical medical_review" href="/z/d/html/8174.html" rel="external">
          "Intra-arterial catheterization for invasive monitoring: Indications, insertion techniques, and interpretation", section on 'Monitoring blood pressure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Normative BP data for EPT infants are primarily based on measurements obtained from a UAC. These factors should be considered when comparing an individual infant's BP values against normative data and deciding whether intervention is indicated [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1376202922">
         <span class="h2">
          Limitations of normative BP ranges
         </span>
         <span class="headingEndMark">
          —
         </span>
         Published nomograms for systolic, diastolic, and mean BP are available for EPT infants based upon normative data [
         <a href="#rid6">
          6,7,15-17
         </a>
         ]. The 5
         <sup>
          th
         </sup>
         or 10
         <sup>
          th
         </sup>
         percentiles on these nomograms are often used to define abnormal BP. Another commonly applied definition is a MAP numerically equivalent to the infant's GA at birth (in weeks) (
         <a class="graphic graphic_figure graphicRef110236" href="/z/d/graphic/110236.html" rel="external">
          figure 2
         </a>
         ). However, we suggest not using these numerical threshold as the sole criteria for therapeutic intervention [
         <a href="#rid4">
          4
         </a>
         ]. Characterizing a low BP value as abnormal or pathologic because if falls below the 5
         <sup>
          th
         </sup>
         or 10
         <sup>
          th
         </sup>
         percentile on these nomograms is problematic because BP values vary considerably during the first 72 hours after birth such that most EPT infants have at least one low systolic, diastolic, or mean BP below the 5
         <sup>
          th
         </sup>
         or 10
         <sup>
          th
         </sup>
         percentile [
         <a href="#rid1">
          1-3,6,7,16,18
         </a>
         ]. Clinically, the difference between the 5
         <sup>
          th
         </sup>
         and 10
         <sup>
          th
         </sup>
         percentile may only be 1 to 2 mmHg. In addition, outcome data from a large prospective cohort reported that early postnatal low BP was not associated with developmental delay at 24 months corrected gestational age (GA) [
         <a href="#rid19">
          19
         </a>
         ]. Thus, additional clinical parameters (eg, capillary refill) must be considered when assessing the adequacy of perfusion and the need for BP intervention. (See
         <a class="local">
          'BP alone is an insufficient measure of perfusion'
         </a>
         below and
         <a class="local">
          'Assessment of perfusion'
         </a>
         below.)
        </p>
        <p>
         Therapeutic intervention based on proposed thresholds for low BP in EPT infants without clinical evidence of poor perfusion is not associated with improved infant outcomes (see
         <a class="local">
          'Outcomes in treated versus untreated infants'
         </a>
         below). As a result, there is no consensus on an accepted threshold for intervention for perceived low BP in EPT infants with adequate perfusion, and in fact, many experts in the field, including the author of this topic, do not think intervention for infants with adequate perfusion is necessary [
         <a href="#rid18">
          18,20
         </a>
         ]. (See
         <a class="local">
          'Adequate peripheral perfusion'
         </a>
         below and
         <a class="local">
          'Outcomes in treated versus untreated infants'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3915025809">
         <span class="h2">
          BP alone is an insufficient measure of perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         In EPT infants, BP alone is not an accurate assessment of global perfusion since BP correlates poorly with organ perfusion, particularly cerebral perfusion [
         <a href="#rid4">
          4,21-31
         </a>
         ]. Several observational studies have reported that cerebral blood or oxygenation based on measurements using near infrared spectroscopy or Doppler sonography were independent of BP changes [
         <a href="#rid22">
          22,24,25,27-31
         </a>
         ]. In addition, a study of 485 infants (mean GA 28.4 weeks) reported BP measurements correlated poorly with left ventricular output [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="local">
          'Assessment of end-organ perfusion'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H504166109">
         <span class="h1">
          ASSESSMENT OF PERFUSION
         </span>
        </p>
        <p class="headingAnchor" id="H895006227">
         <span class="h2">
          General assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         For all extremely preterm (EPT) infants, we monitor blood pressure (BP) measurements either continuously through an umbilical arterial catheter (UAC) or frequently noninvasively with BP cuff (typically hourly) in conjunction with ongoing assessment of peripheral perfusion, acid-base status, and urine output. This general assessment guides further management decisions based primarily on the adequacy of peripheral perfusion and not reliance solely on BP values. (See
         <a class="local">
          'BP alone is an insufficient measure of perfusion'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3771877640">
         <span class="h2">
          Assessment of end-organ perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         In EPT infants, BP and clinical assessment of peripheral perfusion assessment do not reliably reflect end-organ perfusion (eg, cerebral blood flow). As a result, there are ongoing efforts to identify better methods for assessing end-organ perfusion. However, these have not been routinely incorporated into the management of EPT infants in most neonatal intensive care units (NICUs).
        </p>
        <p>
         These include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Echocardiography
         </strong>
         – Echocardiography is a readily available noninvasive tool for the care of extremely preterm infants that can evaluate cardiac function, the presence of congenital heart disease, severity of pulmonary arterial hypertension, and shunting of blood through atrial, ventricular, or great vessel channels [
         <a href="#rid33">
          33,34
         </a>
         ]. Serial echocardiographic studies, often performed by neonatologists, can assess changes in cardiac function over time and response to therapy, and can help differentiate causes of shock [
         <a href="#rid35">
          35,36
         </a>
         ]. Previous concerns regarding inter- and intra-observer variability and unintended adverse effects (eg, induced pulmonary arterial hypertension) have diminished [
         <a href="#rid36">
          36,37
         </a>
         ]. However, neither routine use of neonatologist-performed echocardiography to guide management nor therapies intended to improve echocardiography measurements of cardiac function have been shown to improve patient outcomes [
         <a href="#rid35">
          35,38-40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Near infrared spectroscopy (NIRS)
         </strong>
         – NIRS is a direct, continuous, noninvasive measure of the oxygen balance of a specific organ. It is most commonly used to measure cerebral oxygenation and perfusion (ie, cerebral oximetry). Although NIRS appears safe with little evidence of adverse effects, data are insufficient to recommend its routine use for the care of EPT infants.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Available evidence does not demonstrate clear clinical benefits with NIRS. In a multicenter randomized trial (COSGOD III) that included 607 preterm infants, treatment guided by cerebral NIRS during the first 15 minutes after birth did not improve survival without cerebral injury compared with standard care (83 versus 79 percent) [
         <a href="#rid41">
          41
         </a>
         ]. In a series of multicenter prospective studies (SafeBoosC), cerebral NIRS monitoring decreased the burden of both cerebral hyperoxia and hypoxia compared with standard care; although this study was not designed to evaluate patient outcomes, both in-hospital and two-year neurodevelopmental outcomes were similar between study patients and controls [
         <a href="#rid42">
          42,43
         </a>
         ]. Similarly, in a subsequent randomized trial of 1601 EPT infants, treatment guided by cerebral NIRS initiated within six hours of birth did not reduce the rates of death, severe brain injury, or serious adverse events at 36 weeks postmenstrual age compared with usual care [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other modalities
         </strong>
         – Other modalities for investigating perfusion in EPT infants, such as non-invasive continuous measures of cardiac output through electrical cardiometry and pulsatility index show promise, but remain investigational due to limited safety and efficacy data [
         <a href="#rid38">
          38,45-47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1115175482">
         <span class="h2">
          Indicators of pending shock
         </span>
         <span class="headingEndMark">
          —
         </span>
         Any of the following findings should raise concern that the neonate may progress to a shock state with poor end-organ perfusion. Urgent evaluation and treatment are required in these circumstances (see
         <a class="medical medical_review" href="/z/d/html/126605.html" rel="external">
          "Neonatal shock: Management"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         BP fails to rise spontaneously or drops over time (
         <a class="graphic graphic_figure graphicRef110236" href="/z/d/graphic/110236.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef110237" href="/z/d/graphic/110237.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="local">
          'Physiological changes in BP'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical signs of decreased peripheral perfusion such as cool extremities, acrocyanosis, and pallor. Environmental factors such as hypothermia can have an effect on perfusion in extremely preterm infants and should be promptly identified and addressed. (See
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Decreased peripheral perfusion'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laboratory abnormalities indicative of poor global perfusion (ie, metabolic acidosis with low serum/plasma bicarbonate and elevated blood lactate level). (See
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Laboratory findings'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H915208444">
         <span class="h1">
          MANAGEMENT APPROACH
         </span>
        </p>
        <p class="headingAnchor" id="H497000834">
         <span class="h2">
          Poor peripheral perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Immediate intervention is indicated for patients with clinical signs of poor perfusion regardless of the blood pressure (BP) as these infants are in shock. (See
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Initial stabilization'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126605.html" rel="external">
          "Neonatal shock: Management", section on 'Initial stabilization'
         </a>
         .)
        </p>
        <p>
         The following are clinical signs of poor perfusion:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cool extremities.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pallor.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mottled appearance.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Delay in capillary refill &gt;4 seconds.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oliguria (urine output &lt;1 mL/kg/hr for at least 12 hours).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metabolic or lactic acidosis without a known specific etiology (eg, inborn error of metabolism due to mitochondrial disorders, glycogen storage disease or disorders of gluconeogenesis). (See
         <a class="medical medical_review" href="/z/d/html/17216.html" rel="external">
          "Inborn errors of metabolism: Identifying the specific disorder", section on 'Lactate and pyruvate'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3572748519">
         <span class="h2">
          Adequate peripheral perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Our suggested approach to managing extremely preterm (EPT) infants with low BP who have adequate perfusion is as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Confirm reliability of the BP measurement, as technical problems can occur and impact decision-making. The method used for BP measurements should be considered when interpreting the BP value because noninvasive cuff BP measurements (systolic, diastolic, and mean arterial pressure) can be higher than BP values obtained from an umbilical arterial catheter (UAC). (See
         <a class="local">
          'Accuracy and reliability of BP measurements'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the BP is low but perfusion is adequate, we suggest close observation rather than providing therapeutic interventions aimed at increasing BP (eg, isotonic fluid boluses, inotropes, corticosteroids). This is because the available evidence has not demonstrated a clear benefit of these interventions in EPT infants with low BP and there is some concern that they may be harmful. These data are discussed below. (See
         <a class="local">
          'Outcomes in treated versus untreated infants'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Continue to monitor closely for impending signs of poor perfusion. Appropriate monitoring includes:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hourly or continuous BP monitoring.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Clinical assessment and physical examination every two to three hours at a minimum to assess peripheral perfusion.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Measuring urine output every three to four hours. (See
         <a class="medical medical_review" href="/z/d/html/4989.html" rel="external">
          "Neonatal acute kidney injury: Pathogenesis, etiology, clinical presentation, and diagnosis", section on 'Time of first void and urine volume'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Serial blood testing to promptly identify changes in acid/base balance (blood gas) or the hemoglobin/hematocrit level.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For most infants, no further evaluation or invention is required if their clinical course remains stable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         However, intervention is generally warranted if there are signs of evolving neonatal shock such as the following (see
         <a class="local">
          'Indicators of pending shock'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5039.html" rel="external">
          "Neonatal shock: Etiology, clinical manifestations, and evaluation"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sustained decrease in the MAP by more than 5 mmHg that is not related to technical problems or a change in how BP values are obtained.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Failure to observe the expected rise in BP with increasing postnatal age over the first 48 to 72 hours.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Subsequent clinical evidence of poor perfusion (delayed capillary refill, mottling of the skin, cool extremities, weak pulses, oliguria, elevated lactate level). (See
         <a class="local">
          'Assessment of perfusion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3432074983">
         <span class="h1">
          OUTCOMES IN TREATED VERSUS UNTREATED INFANTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Interventions that are used to treat low blood pressure (BP) in extremely preterm (EPT) infants include isotonic fluid boluses, inotropes (eg,
         <a class="drug drug_pediatric" data-topicid="13248" href="/z/d/drug information/13248.html" rel="external">
          dopamine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13243" href="/z/d/drug information/13243.html" rel="external">
          dobutamine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13272" href="/z/d/drug information/13272.html" rel="external">
          epinephrine
         </a>
         ), and corticosteroids (eg,
         <a class="drug drug_pediatric" data-topicid="13361" href="/z/d/drug information/13361.html" rel="external">
          hydrocortisone
         </a>
         ). For EPT infants who have adequate perfusion, it remains unclear whether these interventions have a clinically meaningful impact, and if so, whether they are beneficial or harmful [
         <a href="#rid5">
          5,8,19,20,22,23,48-51
         </a>
         ]. The data addressing these questions are discussed below.
        </p>
        <p>
         The available evidence should be interpreted with caution as it is observational in nature with notable limitations, including small sample size, inclusion of potential confounding variables such as severity of illness and the presence of underlying diseases that can lead to both shock and death (eg, cardiogenic or hypovolemic shock), and heterogeneity of study design with varying definitions of low BP, criteria for intervention, and choice of intervention.
        </p>
        <p>
         The controversy regarding the impact of BP treatment is illustrated by the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Potential harm
         </strong>
         – The following poor outcomes have been reported to be associated with interventions used for low BP in observational studies:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mortality [
         <a href="#rid20">
          20,49,52,53
         </a>
         ].
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intraventricular and periventricular hemorrhage [
         <a href="#rid8">
          8,52-56
         </a>
         ].
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Retinopathy of prematurity (ROP) [
         <a href="#rid57">
          57,58
         </a>
         ].
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bronchopulmonary dysplasia (BPD) [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Necrotizing enterocolitis (NEC) [
         <a href="#rid59">
          59,60
         </a>
         ].
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Deafness [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Impaired neurodevelopment [
         <a href="#rid48">
          48,61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a prospective observational study of 367 EPT infants from the National Institute of Child Health and Human Development Neonatal Research Network, 55 percent received at least one of the following interventions during the first 24 hours after birth: fluid bolus, vasopressor, blood transfusion, corticosteroid therapy [
         <a href="#rid20">
          20
         </a>
         ]. These interventions were most commonly administered to infants with ≥3 low BP values, although they were also commonly administered to infants without documented low BP (28 to 41 percent). Analyses were performed with 14 different definitions of low BP. In a univariate analysis, rates of severe ROP, grade III/IV intraventricular hemorrhage (IVH), and hospital mortality were higher in infants who received ≥1 of these interventions compared with untreated infants. However, these differences were
         <strong>
         </strong>
         no longer significant after controlling for study center, gestational age (GA), severity of illness, and the number of low BP values.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a subsequent report of 331 infants (90 percent of the original cohort), the risk of death or neurodevelopmental impairment at age 18 to 22 months was higher among infants who received one of these interventions in the initial 24 hours compared with untreated infants after controlling for confounding factors (odds ratio 1.84; 95% CI 1.09-3.09) [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Potential benefit
         </strong>
         – In another prospective study of 456 EPT infants, propensity score matching was used to evaluate outcomes in neonates with low BP who received intervention (fluid bolus, vasoactive infusion, or corticosteroids) during the initial three days after birth (n = 119) compared with neonates who had low BP but did not receive intervention (n = 119) [
         <a href="#rid50">
          50
         </a>
         ]. Hospital mortality was similar in both groups but treated infants had a lower rate of grade III/IV IVH compared with untreated infants.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          No effect
         </strong>
         – Other smaller observational studies suggest that patients with untreated low BP (however defined) for EPT infants with adequate perfusion (capillary refill &lt;3 seconds, strong pulse, warm extremities) appear to have similar outcomes to those with normal BP [
         <a href="#rid5">
          5,23,51,62
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4262765142">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Challenges
         </strong>
         – There is lack of consensus regarding the definition for low blood pressure (BP) in extremely preterm (EPT) infants (gestational age [GA] &lt;28
         <sup>
         </sup>
         weeks) and optimal management of low BP in this population is uncertain. Specific challenges include (see
         <a class="local">
          'Challenges'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Physiologic changes – BP values in EPT infants vary considerably depending on the birth weight (BW), GA, and postnatal age (
         <a class="graphic graphic_figure graphicRef110236" href="/z/d/graphic/110236.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef110237" href="/z/d/graphic/110237.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef110007" href="/z/d/graphic/110007.html" rel="external">
          figure 4
         </a>
         ). (See
         <a class="local">
          'Physiological changes in BP'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Difficulty in obtaining reliable measurements – BP can be measured using a transducer on an indwelling umbilical artery catheter (UAC) or with a noninvasive BP cuff. For both methods, it is important to ensure that measurement is performed appropriately so that BP values are reliable and consistent. Noninvasive measurements may be higher than values obtained from a UAC. (See
         <a class="local">
          'Accuracy and reliability of BP measurements'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Limitations of normative BP ranges – Most EPT infants have at least one systolic BP, diastolic BP, or mean arterial pressure (MAP) below the 5
         <sup>
          th
         </sup>
         or 10
         <sup>
          th
         </sup>
         percentile during the first 72 hours after birth. Thus, characterizing a BP value as pathologic because if falls below these thresholds is problematic. (See
         <a class="local">
          'Limitations of normative BP ranges'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         BP is an insufficient measure of perfusion – In EPT infants, BP alone is not an accurate assessment of global perfusion since BP correlates poorly with organ perfusion, particularly cerebral perfusion. (See
         <a class="local">
          'BP alone is an insufficient measure of perfusion'
         </a>
         above and
         <a class="local">
          'Assessment of end-organ perfusion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Distinguishing normal physiologic changes from shock
         </strong>
         – For most EPT infants, BP values that are lower than published normative values usually are transient, reflect normal physiologic changes following delivery, and are not a sign of an underlying disease process. (See
         <a class="local">
          'Assessment of perfusion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, infants with low BP and evidence of poor peripheral perfusion (delayed capillary refill, mottling of the skin, cool extremities, weak pulses, oliguria, metabolic acidosis, and elevated lactate level) are in shock and require urgent intervention to restore adequate perfusion. Management of neonatal shock is directed at the underlying cause, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/126605.html" rel="external">
          "Neonatal shock: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management of low BP with adequate perfusion
         </strong>
         – Our suggested approach to managing EPT infants with low BP who have adequate perfusion is as follows (see
         <a class="local">
          'Adequate peripheral perfusion'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Confirm that the BP measurement is accurate. (See
         <a class="local">
          'Accuracy and reliability of BP measurements'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For most EPT infants, we suggest close observation (watchful waiting) rather than providing therapeutic interventions to increase BP (eg, fluid boluses, inotropes, corticosteroids) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). This is because the available evidence has not demonstrated a clear benefit of these interventions in EPT infants with low BP and there is some concern that they may be harmful. (see
         <a class="local">
          'Adequate peripheral perfusion'
         </a>
         above and
         <a class="local">
          'Outcomes in treated versus untreated infants'
         </a>
         above).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Appropriate monitoring includes:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Hourly or continuous BP monitoring
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Frequent clinical assessment of peripheral perfusion every two to three hours
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Measurement of urine output every three to four hours
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Serial laboratory testing to assess acid/base status and hemoglobin/hematocrit levels
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In most cases, no further evaluation or invention is required if the clinical course remains stable.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         However, prompt intervention is generally warranted if there are signs of evolving neonatal shock, including
         <strong>
          any
         </strong>
         of the following (see
         <a class="local">
          'Indicators of pending shock'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/126605.html" rel="external">
          "Neonatal shock: Management"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Development of clinical signs of poor perfusion (delayed capillary refill, mottling of the skin, cool extremities, weak pulses, oliguria, elevated lactate level) (see
         <a class="local">
          'Assessment of perfusion'
         </a>
         above).
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Sustained drop in the MAP by &gt;5 mmHg.
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Failure of BP to rise as expected with increasing postnatal age.
        </p>
        <p>
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Dempsey EM, Barrington KJ. Treating hypotension in the preterm infant: when and with what: a critical and systematic review. J Perinatol 2007; 27:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laughon M, Bose C, Allred E, et al. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics 2007; 119:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barrington KJ, Janaillac M. Treating hypotension in extremely preterm infants. The pressure is mounting. Arch Dis Child Fetal Neonatal Ed 2016; 101:F188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldsmith JP, Keels E. Recognition and Management of Cardiovascular Insufficiency in the Very Low Birth Weight Newborn. Pediatrics 2022; 149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dempsey EM, Al Hazzani F, Barrington KJ. Permissive hypotension in the extremely low birthweight infant with signs of good perfusion. Arch Dis Child Fetal Neonatal Ed 2009; 94:F241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batton B, Li L, Newman NS, et al. Evolving blood pressure dynamics for extremely preterm infants. J Perinatol 2014; 34:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vesoulis ZA, El Ters NM, Wallendorf M, Mathur AM. Empirical estimation of the normative blood pressure in infants &lt;28 weeks gestation using a massive data approach. J Perinatol 2016; 36:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batton B, Batton D, Riggs T. Blood pressure during the first 7 days in premature infants born at postmenstrual age 23 to 25 weeks. Am J Perinatol 2007; 24:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colan SD, Fujii A, Borow KM, et al. Noninvasive determination of systolic, diastolic and end-systolic blood pressure in neonates, infants and young children: comparison with central aortic pressure measurements. Am J Cardiol 1983; 52:867.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sonesson SE, Broberger U. Arterial blood pressure in the very low birthweight neonate. Evaluation of an automatic oscillometric technique. Acta Paediatr Scand 1987; 76:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker MD, Maisels MJ, Marks KH. Indirect BP monitoring in the newborn. Evaluation of a new oscillometer and comparison of upper- and lower-limb measurements. Am J Dis Child 1984; 138:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dannevig I, Dale HC, Liestøl K, Lindemann R. Blood pressure in the neonate: three non-invasive oscillometric pressure monitors compared with invasively measured blood pressure. Acta Paediatr 2005; 94:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shimokaze T, Akaba K, Saito E. Oscillometric and intra-arterial blood pressure in preterm and term infants: extent of discrepancy and factors associated with inaccuracy. Am J Perinatol 2015; 32:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dionne JM, Bremner SA, Baygani SK, et al. Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis. J Pediatr 2020; 221:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fanaroff JM, Wilson-Costello DE, Newman NS, et al. Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants. Pediatrics 2006; 117:1131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pejovic B, Peco-Antic A, Marinkovic-Eric J. Blood pressure in non-critically ill preterm and full-term neonates. Pediatr Nephrol 2007; 22:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Zadelhoff AC, Poppe JA, Willemsen S, et al. Age-dependent changes in arterial blood pressure in neonates during the first week of life: reference values and development of a model. Br J Anaesth 2023; 130:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Short BL, Van Meurs K, Evans JR, Cardiology Group. Summary proceedings from the cardiology group on cardiovascular instability in preterm infants. Pediatrics 2006; 117:S34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Logan JW, O'Shea TM, Allred EN, et al. Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns. Arch Dis Child Fetal Neonatal Ed 2011; 96:F321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batton B, Li L, Newman NS, et al. Use of antihypotensive therapies in extremely preterm infants. Pediatrics 2013; 131:e1865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cayabyab R, McLean CW, Seri I. Definition of hypotension and assessment of hemodynamics in the preterm neonate. J Perinatol 2009; 29 Suppl 2:S58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garner RS, Burchfield DJ. Treatment of presumed hypotension in very low birthweight neonates: effects on regional cerebral oxygenation. Arch Dis Child Fetal Neonatal Ed 2013; 98:F117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alderliesten T, Lemmers PM, van Haastert IC, et al. Hypotension in preterm neonates: low blood pressure alone does not affect neurodevelopmental outcome. J Pediatr 2014; 164:986.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tyszczuk L, Meek J, Elwell C, Wyatt JS. Cerebral blood flow is independent of mean arterial blood pressure in preterm infants undergoing intensive care. Pediatrics 1998; 102:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munro MJ, Walker AM, Barfield CP. Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 2004; 114:1591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukuda S, Mizuno K, Kakita H, et al. Late circulatory dysfunction and decreased cerebral blood flow volume in infants with periventricular leukomalacia. Brain Dev 2008; 30:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lightburn MH, Gauss CH, Williams DK, Kaiser JR. Cerebral blood flow velocities in extremely low birth weight infants with hypotension and infants with normal blood pressure. J Pediatr 2009; 154:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishimaki S, Iwasaki S, Minamisawa S, et al. Blood flow velocities in the anterior cerebral artery and basilar artery in asphyxiated infants. J Ultrasound Med 2008; 27:955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romagnoli C, Giannantonio C, De Carolis MP, et al. Neonatal color Doppler US study: normal values of cerebral blood flow velocities in preterm infants in the first month of life. Ultrasound Med Biol 2006; 32:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papacci P, Giannantonio C, Cota F, et al. Neonatal colour Doppler ultrasound study: normal values of abdominal blood flow velocities in the neonate during the first month of life. Pediatr Radiol 2009; 39:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ilves P, Lintrop M, Talvik I, et al. Developmental changes in cerebral and visceral blood flow velocity in healthy neonates and infants. J Ultrasound Med 2008; 27:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kharrat A, Rios DI, Weisz DE, et al. The Relationship between blood pressure parameters and left ventricular output in neonates. J Perinatol 2019; 39:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noori S, Seri I. Evidence-based versus pathophysiology-based approach to diagnosis and treatment of neonatal cardiovascular compromise. Semin Fetal Neonatal Med 2015; 20:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giesinger RE, McNamara PJ. Hemodynamic instability in the critically ill neonate: An approach to cardiovascular support based on disease pathophysiology. Semin Perinatol 2016; 40:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Waal K, Kluckow M. Superior vena cava flow: Role, assessment and controversies in the management of perinatal perfusion. Semin Fetal Neonatal Med 2020; 25:101122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Boode WP, van der Lee R, Horsberg Eriksen B, et al. The role of Neonatologist Performed Echocardiography in the assessment and management of neonatal shock. Pediatr Res 2018; 84:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makoni M, Chatmethakul T, Giesinger R, McNamara PJ. Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography. J Vis Exp 2023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dempsey EM, El-Khuffash AF. Objective cardiovascular assessment in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 2018; 103:F72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh Y, Gupta S, Groves AM, et al. Expert consensus statement 'Neonatologist-performed Echocardiography (NoPE)'-training and accreditation in UK. Eur J Pediatr 2016; 175:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahde Bischoff A, Bhombal S, Altman CA, et al. Targeted Neonatal Echocardiography in Patients With Hemodynamic Instability. Pediatrics 2022; 150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pichler G, Goeral K, Hammerl M, et al. Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial. BMJ 2023; 380:e072313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hyttel-Sorensen S, Pellicer A, Alderliesten T, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ 2015; 350:g7635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plomgaard AM, Schwarz CE, Claris O, et al. Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial. PLoS One 2022; 17:e0262640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen ML, Pellicer A, Hyttel-Sørensen S, et al. Cerebral Oximetry Monitoring in Extremely Preterm Infants. N Engl J Med 2023; 388:1501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gatelli IF, Vitelli O, Fossati M, et al. Neonatal Septic Shock and Hemodynamic Monitoring in Preterm Neonates in an NICU: Added Value of Electrical Cardiometry in Real-Time Tailoring of Management and Therapeutic Strategies. Am J Perinatol 2022; 39:1401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwarz CE, Livingstone V, O'Toole JM, et al. Agreement of Cardiac Output Estimates between Electrical Cardiometry and Transthoracic Echocardiography in Very Preterm Infants. Neonatology 2022; 119:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garvey AA, O'Neill R, Livingstone V, et al. Non-invasive continuous cardiac output monitoring in infants with hypoxic ischaemic encephalopathy. J Perinatol 2022; 42:1622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batton B, Li L, Newman NS, et al. Early blood pressure, antihypotensive therapy and outcomes at 18-22 months' corrected age in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed 2016; 101:F201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ewer AK, Tyler W, Francis A, et al. Excessive volume expansion and neonatal death in preterm infants born at 27-28 weeks gestation. Paediatr Perinat Epidemiol 2003; 17:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durrmeyer X, Marchand-Martin L, Porcher R, et al. Abstention or intervention for isolated hypotension in the first 3 days of life in extremely preterm infants: association with short-term outcomes in the EPIPAGE 2 cohort study. Arch Dis Child Fetal Neonatal Ed 2017; 102:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Batton B, Zhu X, Fanaroff J, et al. Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants. J Pediatr 2009; 154:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall RW, Kronsberg SS, Barton BA, et al. Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial. Pediatrics 2005; 115:1351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vesoulis ZA, Flower AA, Zanelli S, et al. Blood pressure extremes and severe IVH in preterm infants. Pediatr Res 2020; 87:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faust K, Härtel C, Preuß M, et al. Short-term outcome of very-low-birthweight infants with arterial hypotension in the first 24 h of life. Arch Dis Child Fetal Neonatal Ed 2015; 100:F388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al Tawil KI, El Mahdy HS, Al Rifai MT, et al. Risk factors for isolated periventricular leukomalacia. Pediatr Neurol 2012; 46:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaveri PG, Walker AM, Upadhyay K, Talati AJ. Use of Vasopressors in Extremely Preterm Infants in First Week of Life. Am J Perinatol 2023; 40:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yau GS, Lee JW, Tam VT, et al. Risk factors for retinopathy of prematurity in extremely preterm Chinese infants. Medicine (Baltimore) 2014; 93:e314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catenacci M, Miyagi S, Wickremasinghe AC, et al. Dopamine-resistant hypotension and severe retinopathy of prematurity. J Pediatr 2013; 163:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong J, Shah PS, Yoon EW, et al. Inotrope use among extremely preterm infants in Canadian neonatal intensive care units: variation and outcomes. Am J Perinatol 2015; 32:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gephart SM, Spitzer AR, Effken JA, et al. Discrimination of GutCheck(NEC): a clinical risk index for necrotizing enterocolitis. J Perinatol 2014; 34:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martens SE, Rijken M, Stoelhorst GM, et al. Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants? Early Hum Dev 2003; 75:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dempsey EM, Barrington KJ, Marlow N, et al. Hypotension in Preterm Infants (HIP) randomised trial. Arch Dis Child Fetal Neonatal Ed 2021; 106:398.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 109813 Version 12.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17653217" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Treating hypotension in the preterm infant: when and with what: a critical and systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17272616" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26785856" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Treating hypotension in extremely preterm infants. The pressure is mounting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35224636" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Recognition and Management of Cardiovascular Insufficiency in the Very Low Birth Weight Newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19174413" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Permissive hypotension in the extremely low birthweight infant with signs of good perfusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24503912" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Evolving blood pressure dynamics for extremely preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26633144" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Empirical estimation of the normative blood pressure in infants&lt;28 weeks gestation using a massive data approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17304424" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Blood pressure during the first 7 days in premature infants born at postmenstrual age 23 to 25 weeks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6624679" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Noninvasive determination of systolic, diastolic and end-systolic blood pressure in neonates, infants and young children: comparison with central aortic pressure measurements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3591301" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Arterial blood pressure in the very low birthweight neonate. Evaluation of an automatic oscillometric technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6741895" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Indirect BP monitoring in the newborn. Evaluation of a new oscillometer and comparison of upper- and lower-limb measurements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15981753" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Blood pressure in the neonate: three non-invasive oscillometric pressure monitors compared with invasively measured blood pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24971570" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Oscillometric and intra-arterial blood pressure in preterm and term infants: extent of discrepancy and factors associated with inaccuracy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32446487" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16585307" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17053885" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Blood pressure in non-critically ill preterm and full-term neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36858885" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Age-dependent changes in arterial blood pressure in neonates during the first week of life: reference values and development of a model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16777820" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Summary proceedings from the cardiology group on cardiovascular instability in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21138828" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23650301" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Use of antihypotensive therapies in extremely preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19399011" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Definition of hypotension and assessment of hemodynamics in the preterm neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22782995" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Treatment of presumed hypotension in very low birthweight neonates: effects on regional cerebral oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24484771" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Hypotension in preterm neonates: low blood pressure alone does not affect neurodevelopmental outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9685435" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Cerebral blood flow is independent of mean arterial blood pressure in preterm infants undergoing intensive care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15574619" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Hypotensive extremely low birth weight infants have reduced cerebral blood flow.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18367356" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Late circulatory dysfunction and decreased cerebral blood flow volume in infants with periventricular leukomalacia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19324371" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cerebral blood flow velocities in extremely low birth weight infants with hypotension and infants with normal blood pressure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18499855" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Blood flow velocities in the anterior cerebral artery and basilar artery in asphyxiated infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16530090" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Neonatal color Doppler US study: normal values of cerebral blood flow velocities in preterm infants in the first month of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19189099" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Neonatal colour Doppler ultrasound study: normal values of abdominal blood flow velocities in the neonate during the first month of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18204010" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Developmental changes in cerebral and visceral blood flow velocity in healthy neonates and infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30770881" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : The Relationship between blood pressure parameters and left ventricular output in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25823937" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Evidence-based versus pathophysiology-based approach to diagnosis and treatment of neonatal cardiovascular compromise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26778235" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Hemodynamic instability in the critically ill neonate: An approach to cardiovascular support based on disease pathophysiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32467039" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Superior vena cava flow: Role, assessment and controversies in the management of perinatal perfusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30072807" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The role of Neonatologist Performed Echocardiography in the assessment and management of neonatal shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36779612" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29127152" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Objective cardiovascular assessment in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26362538" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Expert consensus statement 'Neonatologist-performed Echocardiography (NoPE)'-training and accreditation in UK.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36317979" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Targeted Neonatal Echocardiography in Patients With Hemodynamic Instability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36693654" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25569128" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35073354" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37075142" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Cerebral Oximetry Monitoring in Extremely Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33723835" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Neonatal Septic Shock and Hemodynamic Monitoring in Preterm Neonates in an NICU: Added Value of Electrical Cardiometry in Real-Time Tailoring of Management and Therapeutic Strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35896077" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Agreement of Cardiac Output Estimates between Electrical Cardiometry and Transthoracic Echocardiography in Very Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36056257" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Non-invasive continuous cardiac output monitoring in infants with hypoxic ischaemic encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26567120" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Early blood pressure, antihypotensive therapy and outcomes at 18-22 months' corrected age in extremely preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12675785" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Excessive volume expansion and neonatal death in preterm infants born at 27-28 weeks gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28302697" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Abstention or intervention for isolated hypotension in the first 3 days of life in extremely preterm infants: association with short-term outcomes in the EPIPAGE 2 cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19026429" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15867047" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31578033" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Blood pressure extremes and severe IVH in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26199082" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Short-term outcome of very-low-birthweight infants with arterial hypotension in the first 24 h of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22353288" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Risk factors for isolated periventricular leukomalacia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33990125" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Use of Vasopressors in Extremely Preterm Infants in First Week of Life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25526484" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Risk factors for retinopathy of prematurity in extremely preterm Chinese infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23465406" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Dopamine-resistant hypotension and severe retinopathy of prematurity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24705971" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Inotrope use among extremely preterm infants in Canadian neonatal intensive care units: variation and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24651734" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Discrimination of GutCheck(NEC): a clinical risk index for necrotizing enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14652161" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33627329" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Hypotension in Preterm Infants (HIP) randomised trial.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
